Galveston-based University of Texas Medical Branch recently inked a five-year deal with Microsoft to take advantage of the company’s AI and cloud computing capabilities, its CIO told Becker’s. This ...

In the new book The AI Con, AI critics Emily Bender and Alex Hanna break down the smoke and mirrors around generative AI.

CEO Dan O'Connell reported that Acumen completed enrollment of its 542-participant Phase 2 ALTITUDE-AD study evaluating Sabirnetug for early Alzheimer’s disease, stating, "We completed enrollment of ...